Registry of Lobbyists
Version 3 of 8 (1997-06-26 to 1998-01-19) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Organization: |
CANADIAN SOCIETY OF HOSPITAL PHARMACISTS (CSHP)
350 - 1145 HUNT CLUB ROAD OTTAWA, ON K1V 0Y3 Canada |
| Telephone number: | 613-736-9733 |
| Fax number: | 613-736-5660 |
| Responsible officer name and position during the period of this registration: | WILLIAM J LESLIE, EXECUTIVE DIRECTOR |
| Description of the organization's activities: | THE CANADIAN SOCIETY OF HOSPITAL PHARMACISTS (CSHP) IS THE NATIONAL VOLUNTARY ORGANIZATION OF PHARMACISTS WHO SHARE AN INTEREST IN PHARMACY PRACTICE IN HOSPITALS AND RELATED HEALTH CARE SETTINGS.CSHP'S VISION IS: COMMITTED CAREGIVERS.... CHALLENGING EACH OTHER THROUGH SHARING & EDUCATION , LEADING PHARMACY THROUGH STANDARDS & INNOVATION. THE RELATED VISION OBJECTIVES ARE: 1- ENCOURAGE MEMBERS TO DEVELOP & SHARE INNOVATIVE DIRECT PATIENT CARE PRACTIVE MODELS & EXPERIENCE2- PROMOTE THE DIRECT PATIENT CARE ROLE OF THE PHARMACIST TO: MEMBERS, PATIENTS, EDUCATORS, STUDENTS, GOV'T, HEALTH CARE PROVIDERS & ORGANIZATIONS3- PROVIDE ACCESSIBLE EDUCATION TO ASSIST MEMBERS IN ACHIEVING A DIRECT PATIENT CARE ROLE |
| Organization's membership or classes of membership: | 1-ACTIVE MEMBERS ARE PHARMACISTS LICENSED OR REGISTERED WITH A PHARMACY REGULATORY BODY IN CANADA OR PERSONS WITH A PROFESSIONAL DEGREE IN PHARMACY2-HONORARY MEMBERS - ELECTED BY A 2/3 VOTE OF THE COUNCIL OF THE SOCIETY3-STUDENT MEMBERS ARE PERSONS ENROLLED IN A BACCALAUREATE DEGREE PROGRAM IN PHARMACY4-SUPPORTING MEMBERS ARE PERSONS NOT ELIGIBLE FOR OTHER MEMBERSHIP CATEGORIES5-CORPORATE MEMBERS ARE CORPORATIONS WHO SUPPORT THE OBJECTIVES OF AND PAY FEES TO THE SOCIETY |
| Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | WILLIAM LESLIE |
| Position title: | EXECUTIVE DIRECTOR |
| Public offices held: | N/A. Disclosure of this information was not a requirement prior to June 20, 2005. |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | DRUGS DIRECTORATE, HEALTH PROTECTION BRANCH, Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Health |
| Subject Matter: Retrospective: | RESPONSES TO REQUESTS FOR INPUT: RX TO OTC SWITCH FOR NICORETTE GUM 4 MG.; REGULATIONS FOR WOMEN IN CLINICAL TRIALS; REGULATIONS FOR HUMAN NEW DRUG SUBMISSION [ BIOTECHNOLOGY]; REGULATIONS FOR PRODUCT MONOGRAPHS; REGULATIONS FOR ESTABLISHMENT LICENSES; COMPARATIVE DRUG ADVERTISING CLAIMS; BIOEQUIVALENCE REQUIREMENTS; REGS FOR NEW CONTROLLED SUBSTANCES ACT; GUIDELINES FOR RADIOPHARMACEUTICAL Q.A.; REGS FOR COSMETIC PRODUCTS - LABEL & CLAIM ISSUES; SPECIAL ACCESS PROGRAM; REGS FOR SUPPLEMENTAL NEW DRUG SUBMISSIONS; RX TO OTC SWITCH FOR RANITIDINE 75 MG.; STANDARDS FOR COMPARATIVE BIOAVAILABILITY STUDIES; NOTICE OF COMPLIANCE WITH CONDITIONS POLICY; PRINCIPLES FOR DIRECT TO CONSUMER ADS; NUMEROUS MEETINGS RE: ESTABLISHMENT LICENSES & HOSPITAL COMPOUNDING PRACTICES (GMP & HOSPITAL PHARMACY); C-91 [ DRUG PATENTS]; PARTIPATION IN HEALTH CANADA'S WORKSHOPS ON ANTIBIOTIC RESISTANCE & ON CFC PROPELLANTS. |
| Subject Matter: Prospective: | RESPOND TO RELEVANT HEALTH RELATED ITEMS PUBLISHED IN CANADA GAZETTE; ALSO TO ADVANCE NOTICE REGULATORY LETTERS FROM DRUGS DIRECTORATE.RESPOND TO REQUESTS FOR COMMENT FROM PMPRB.CONTINUING DISSCUSSIONS WITH D.D. REGARDING APPLICATIONS OF GMP TO HOSPITAL PHARMACY & RELATED ISSUE OF ESTABLISHMENT LICENSES.. |